Human Skin Aging: Clinical Parameters and Gene Expression Profiling

NCT ID: NCT01451476

Last Updated: 2024-02-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

122 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-05-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Skin aging is a complex process involving genetic and environmental factors. The investigators hope to learn more about how human genes and their function can contribute to skin aging and human health.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study includes answering a survey on prior sun exposures, donating two small pieces of skin (4mm each), one blood draw, complexion analysis, photographs, and non-invasive tests such as skin surface lipid analysis. Your blood and tissue will be sent for DNA analysis and gene expression profiling.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ageing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy females aged >=18

Healthy female volunteers of skin type I or II

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy female, age 18 or older,
* Fitzpatrick type 1 or 2 skin,
* able to read and understand written consent form,
* body mass index normal or overweight range,
* willing to take blood tests and donate skin samples

Exclusion Criteria

* pregnant or lactating,
* history of cosmetic surgery affecting the face,
* use of prescription anti-aging medications for 2 weeks prior to study,
* use of dietary supplements for 2 weeks prior to study, use of tanning beds or excessive light exposure (\>2 hours) in the past 2 weeks,
* medical conditions which at the discretion of the investigator will have significant impact on ability to judge subjects' skin characteristics and age, sunless tanner use in past 2 weeks
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Anne Chang

instructor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alfred Lane, MD

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Anne Chang, MD

Role: STUDY_DIRECTOR

Stanford University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Stanford Dermatology

Redwood City, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Xu J, Spitale RC, Guan L, Flynn RA, Torre EA, Li R, Raber I, Qu K, Kern D, Knaggs HE, Chang HY, Chang AL. Novel Gene Expression Profile of Women with Intrinsic Skin Youthfulness by Whole Transcriptome Sequencing. PLoS One. 2016 Nov 9;11(11):e0165913. doi: 10.1371/journal.pone.0165913. eCollection 2016.

Reference Type RESULT
PMID: 27829007 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

003

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

HSA_GEP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Secretome Treatment for Facial Rejuvenation
NCT07227883 RECRUITING EARLY_PHASE1
Mechanisms for Laser-Induced Rejuvenation
NCT06489301 NOT_YET_RECRUITING NA